Operationalise the Centre for Commercialisation for Regenerative Medicine Australia


  • 12 Jul 2018

This project will see CCRM Australia accelerating the commercialization of Australian regenerative medicine technologies, therapies and related products.

CCRM will achieve this by fostering increased collaboration between industry, clinicians and academia, both locally and globally; and nurturing local regenerative medicine companies for the international market.

Visit CCRM Australia's website for more details.

Twitter: ccrm_au

Consortium leadMonash University
Consortium membersAustralian Regenerative Medicine Institute (ARMI), CCRM (Canada), Bioplatforms Australia (BPA), Cell Therapy Manufacturing CRC, ReNerve Pty Ltd, Cynata Therapeutics Ltd, Regeneus Ltd & Australian Red Cross Blood Service
MTPConnect grant$340,000
Industry contribution$341,000
Project durationJanuary 2018 - October 2019
ContactSilvio Tiziani, Monash University - silvio.tiziani@monash.edu